A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene.

TitleA novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene.
Publication TypeJournal Article
Year of Publication2012
AuthorsTan Y-C, Michaeel A, Blumenfeld J, Donahue S, Parker T, Levine D, Rennert H
JournalJ Mol Diagn
Date Published2012 Jul
KeywordsFemale, Genetic Testing, Humans, Polycystic Kidney, Autosomal Dominant, Polymerase Chain Reaction, TRPP Cation Channels

Genetic testing of PKD1 and PKD2 is useful for the diagnosis and prognosis of autosomal dominant polycystic kidney disease; however, analysis is complicated by the large transcript size, the complexity of the gene region, and the high level of gene variations. We developed a novel mutation screening assay for PKD1 by directly sequencing long-range (LR) PCR products. By using this method, the entire PKD1 coding region was amplified by nine reactions, generating product sizes from 2 to 6 kb, circumventing the need for specific PCR amplification of individual exons. This method was compared with direct sequencing used by a reference laboratory and the SURVEYOR-WAVE Nucleic Acid High Sensitivity Fragment Analysis System (Transgenomic) screening method for five patients with autosomal dominant polycystic kidney disease. A total of 53 heterozygous genetic changes were identified by LR PCR sequencing, including 41 (of 42) variations detected by SURVEYOR nuclease and all 32 variations reported by the reference laboratory, detecting an additional 12 intronic changes not identified by the other two methods. Compared with the reference laboratory, LR PCR sequencing had a sensitivity of 100%, a specificity of 98.5%, and an accuracy of 98.8%; compared with the SURVEYOR-WAVE method, it had a sensitivity of 97.1%, a specificity of 100%, and an accuracy of 99.4%. In conclusion, LR PCR sequencing was superior to the direct sequencing and screening methods for detecting genetic variations, achieving high sensitivity and improved intronic coverage with a faster turnaround time and lower costs, and providing a reliable tool for complex genetic analyses.

Alternate JournalJ Mol Diagn
PubMed ID22608885
PubMed Central IDPMC3391417
Grant ListUL1RR024143 / RR / NCRR NIH HHS / United States
Related Lab: 
Related Faculty: 
Hanna Rennert, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700